Price History

Hover for the daily close. The dotted line marks the period open.

Compare MBOT with… →

MBOT Key Statistics

As of Sep 4, 2026

Trading

Open: $1.48
Previous Close: $1.44
Day's Range: 1.44–1.48
52-Week Range: 1.44–4.67
Volume: 406.40K
Beta: 1.03

Valuation

Market Cap: $96.72M
P/E Ratio: unprofitable
PEG Ratio: 0.70
P/S ratio: 279.53
EPS (ttm): −0.25

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): −$13.14M
Profit margin: 0.00%
Shares Outstanding: 67.16M
1-Year Return: −57.27%

Dividend and dates

Avg Volume: 725.46K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MBOT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−88.76%+491.28%−28.00%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	−28.00%
2025	+78.57%
2024	−31.71%
2023	−45.51%
2022	−59.87%
2021	+8.85%
2020	−32.25%
2019	+491.28%
2018	−88.76%
2017	−83.28%
2016 (partial year)	+78.36%

As of September 4, 2026.

MBOT Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	−$13.14M	—
2024	$0.00	−$11.44M	—
2023	$0.00	−$10.74M	—
2022	$0.00	−$13.17M	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	—	−$14.74M	−$13.14M	—
2024	$0.00	—	−$11.63M	−$11.44M	—
2023	$0.00	—	−$10.14M	−$10.74M	—
2022	$0.00	—	−$13.44M	−$13.17M	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MBOT Valuation vs Medical Devices Median

Median of 151 stocks

Metric	MBOT	Medical Devices median	vs median
P/S ratio	279.53	2.98	93.9x the median
Profit margin	0.00%	−1.69%	1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Microbot Medical Inc. (MBOT) at $96.72M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 43 employees.

Over the past 52 weeks the price has ranged from $1.44 to $4.67. MBOT last closed at $1.44 on September 4, 2026. The close was unchanged from the previous session.

Financial Health

In fiscal 2025, Microbot Medical Inc. reported revenue of $0.00. The same year closed with a net loss of $13.14M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −0.25.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.7. The price-to-sales ratio is 279.53. On price-to-sales that is 93.9 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −57.27%. Across 10 years the annualized return works out at −39.18%. The reported beta is 1.03. Daily returns over the trailing 10 years annualize to a volatility of 151.46%.

Growth & Income

No dividend is on file for MBOT.

So far in 2026 the price is −28.00%. The strongest complete calendar year on file is 2019 at +491.28%; the weakest is 2018 at −88.76%. Of the 9 complete calendar years on file, 3 finished higher.

Peer Comparison

Microbot Medical Inc. (MBOT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Microbot Medical Inc.	MBOT	$96.72M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Microbot Medical Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

EW

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Microbot Medical Inc.

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Visit website →

Microbot Medical Inc. (MBOT) Stock Analysis